So if regeneron/ Eli Lilly get approved for m/m viral stage does that imply that we might only be getting the smaller percentage that don’t respond and develop into immunological stage of virus?

It seems like BP are choking off revenue.
LL has been described by some on this or another board as a Swiss Army knife type of deal.
The problem with the multi tool analogy is that there are far better suited tools for each of the jobs the army knife does.
How fast can BP pull them out their toll boxes.....is what I wonder about.
Really hope we get approval for HIV soon as this is our bread and butter for the foreseeable future.
Completely long however I think we would be wise to temper expectations on Covid. Happy if I am wrong though.